Charles River Laboratories International, Inc. (CRL)
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Charles River (CRL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Charles River Laboratories (CRL) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report?
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
Algert Global LLC Buys 39,586 Shares of Charles River Laboratories International, Inc. $CRL
Algert Global LLC increased its stake in Charles River Laboratories International, Inc. (NYSE: CRL) by 54.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 112,870 shares of the medical research company's stock after purchasing an additional 39,586 shares during
Charles River Laboratories International, Inc. (CRL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Charles River Laboratories International, Inc. (CRL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Charles River Laboratories International, Inc. (CRL) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Charles River Laboratories International, Inc. (CRL) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Why Charles River Laboratories (CRL) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investing in Charles River (CRL)? Don't Miss Assessing Its International Revenue Trends
Evaluate Charles River's (CRL) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Charles River Laboratories Q4 Review: Approaching A Bottom
Charles River Laboratories Q4 Review: Approaching A Bottom
Here's What Key Metrics Tell Us About Charles River (CRL) Q4 Earnings
Although the revenue and EPS for Charles River (CRL) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CRL Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise
Charles River tops Q4 earnings and revenue estimates as margins expand, but shares dip, and organic growth declines across all segments.
